Viewing Study NCT04417166


Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2025-12-25 @ 2:17 PM
Study NCT ID: NCT04417166
Status: RECRUITING
Last Update Posted: 2025-01-30
First Post: 2020-06-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module